Ferring Switzerland

Ferring invests heavily in the process of creating new medicines through its research and development centres and through research collaboration with scientific institutes, as well as biotechnology and pharmaceutical companies throughout the world. Ferring’s R&D activities are focused on the development of first-in-class therapeutic peptides and proteins in our key therapeutic areas: reproductive health, urology, gastroenterology and endocrinology.